ANSWER AND REASONINGE. Definitive intensity-modulated radiotherapy with concurrent systemic therapy in a specialist MDT
For non-metastatic locally advanced NPC, definitive chemoradiotherapy—not heroic resection—is the core curative strategy.
Why every option is right or wrong
A. Primary open skull-base resection: Morbidity is high and definitive chemoradiotherapy is standard for locally advanced disease.
B. Neck dissection as sole treatment: This does not treat the primary or skull-base extension.
C. Radiotherapy to the nasopharynx alone without systemic therapy: Locally advanced disease generally requires concurrent systemic treatment when fit.
D. Palliative steroids only because carotid encasement precludes cure: Carotid/cavernous extension does not automatically make non-metastatic NPC incurable.
E. Definitive intensity-modulated radiotherapy with concurrent systemic therapy in a specialist MDT: NPC is primarily chemoradiosensitive; modern target delineation must cover skull-base and nodal risk while respecting critical structures.
What if the scenario changed?
If staging demonstrated widespread metastases, systemic therapy and symptom-directed radiotherapy would replace definitive locoregional treatment alone.